The Kidney Cancer Program (KCP) has received a $500,000 philanthropic award from the Pasarow Foundation to launch the Patient Laboratory—an effort to transform how we study and care for patients with kidney cancer.
Cancer research is at an inflection point. Advances in molecular profiling, spatial biology, single-cell analysis, digital pathology, proteomics, serial liquid biopsy, and artificial intelligence now enable unprecedented characterization of a patient’s cancer and treatment response. Yet these technologies largely remain in specialized labs offering limited benefit to patients. Our goal in the Kidney Cancer Patient Laboratory is for each patient to become a research laboratory bringing together providers and scientists into an unprecedented longitudinal patient-centered journey integrating discovery and care. Linking clinical presentation to in-depth understanding of disease biology and longitudinal treatment interventions with detailed analyses of their impact on the cancer ecosystem has the potential to revolutionize cancer research and treatment.
The vision is to deeply characterize individual patient tumors by bringing together the latest technologies. Multiple technologies will be applied simultaneously to the same patient specimens and linked to detailed clinical, imaging, pathological, and longitudinal outcome data. Investigators will become active members of multidisciplinary patient research and care teams, working alongside physicians. To date, 31 investigators have been incorporated.
By integrating mechanistic science with clinical decision-making, we hope to create a new research and patient care model—one in which discoveries emerge from the comprehensive study of individual patients and inform future patient care.
Second Call for Investigators
We are seeking additional participation from UT Southwestern faculty investigators. We invite basic and translational researchers with technologies or analytical approaches that complement existing approaches.
Faculty who would like to participate in multidisciplinary patient research and care discussions are also welcome even if they don’t have a technology to contribute.
Building on KCP Resources
This initiative will synergize with several key KCP resources:
- Kidney Cancer Explorer, a database integrating clinical and research data in real time.
- The SPARK collaboration with Regeneron, which includes whole-exome sequencing (WES) and RNAseq of our kidney cancer library (>3,000 primary tumors and metastases) with a planned expansion to include FFPE samples.
- A collaboration with Natera, enabling prospective collection and analysis of circulating tumor DNA (ctDNA) to monitor disease evolution, treatment response, and minimal residual disease over time.
- Our tumorgraft platform enabling functional studies and mechanistic investigation using patient-derived mouse models (>200 models).
- Other ongoing efforts in digital pathology and organoids.
Together, these complementary efforts create an unprecedented opportunity to understand kidney cancer across multiple scales—from tissue architecture and genomics to circulating biomarkers and functional modeling.
Investigators and Research Areas
A Unique Opportunity
This initiative offers a rare opportunity for basic/translational scientists to become directly engaged in patient-centered research alongside clinicians delivering patient care. Participating investigators will work closely with medical oncologists, surgeons, radiation oncologists, pathologists, radiologists, computational scientists, and other investigators.
The project leadership team—Dr. James Brugarolas, Dr. Payal Kapur, and Dr. Vitaly Margulis—is available to discuss proposals with interested faculty.
We hope you will join us in building the Kidney Cancer Patient Laboratory.
Application and Pilot Funding
Investigators proposing a technology should submit a one-page application that includes:
- One to two paragraphs describing the proposed technology or analytical approach, the scientific questions it will address, and its contribution to the Patient Laboratory.
- A lean budget outlining anticipated per-patient and per-sample costs, with justification of reagents, assays, or technology-related expenses.
Funding is intended to support direct costs required to implement the proposed technology. Personnel costs should not be included. Samples will be provided to investigators free of charge along with histology services.
Eligibility: UT Southwestern faculty investigators
Application deadline: December 13, 2026
Submission: KCPDRA@utsouthwestern.edu
Faculty interested in participating without proposing a technology may contact the same address.





